Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015056
Filing Date
2025-05-30
Accepted
2025-05-30 19:28:38
Documents
2
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 form4-05302025_110532.html 4  
1 form4-05302025_110532.xml 4 4081
2 ex24-05302025_110532.htm EX-24 6483
  Complete submission text file 0001415889-25-015056.txt   12064
Mailing Address ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Islam Saqib (Reporting) CIK: 0001575408 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 251012781

Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)